Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
The pathogenesis of splenic marginal zone lymphoma (SMZL) remains largely unknown. Recent high-throughput sequencing studies have identified recurrent mutations in key pathways, most notably NOTCH2 mutations in >25% of patients. These studies are based on small, heterogeneous discovery cohorts, a...
Main Authors: | Marina Parry, Matthew J J Rose-Zerilli, Jane Gibson, Sarah Ennis, Renata Walewska, Jade Forster, Helen Parker, Zadie Davis, Anne Gardiner, Andrew Collins, David G Oscier, Jonathan C Strefford |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24349473/?tool=EBI |
Similar Items
-
Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma
by: Parry, Marina, et al.
Published: (2013) -
Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma
by: Carolina Jaramillo Oquendo, et al.
Published: (2019-07-01) -
Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease
by: Rose-Zerilli, Matthew, et al.
Published: (2016) -
Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing
by: Parry, Marina, et al.
Published: (2015) -
The outcome of chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with
by: Davis, Zadie, et al.
Published: (2016)